Skip to main content

Table 1 Demographic characteristics and the neuropsychological assessments among study participants

From: Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

 

Total

Clinical diagnosis

NC

aMCI-s

aMCI-m

Mild AD

Moderate AD

Severe AD

 

CDR = 0

CDR = 0.5

CDR = 0.5

CDR = 1

CDR = 2

CDR = 3

 

\Demographic characteristics

(N = 451)

(N = 131)

(N = 39)

(N = 113)

(N = 67)

(N = 63)

(N = 38)

P value

 Gender, female, n (%)

260 (57.6)

82 (62.6)

14 (35.9)

69 (61.1)

31 (46.3)

38 (60.3)

26 (68.4)

0.011

 Age, y, mean (SD)

68.6 (8.8)

69.2 (7.1)

69.6 (9.3)

70.0 (8.0)

67.7 (9.7)

69.1 (10.8)

62.3 (8.2)

<0.001

 Education years, mean (SD)

10.3 (4.1)

11.8 (2.9)

13.6 (3.6)

10.2 (3.6)

10.3 (3.6)

8.4 (4.6)

5.6 (4.0)

<0.001

 Smoking, n (%)

79 (17.5)

17 (13.0)

5 (12.8)

23 (20.4)

15 (22.4)

12 (19.0)

7 (18.4)

0.529

 Alcohol consumption, n (%)

77 (17.1)

19 (14.5)

4 (10.3)

21 (18.6)

18 (26.9)

12 (19.0)

3 (7.9)

0.139

 Hypertension, n (%)

168 (37.3)

53 (40.5)

17 (43.6)

44 (38.9)

23 (34.3)

22 (34.9)

9 (23.7)

0.461

 Diabetes mellitus, n (%)

68 (15.1)

19 (14.5)

7 (17.9)

19 (16.8)

8 (11.9)

10 (15.9)

5 (13.2)

0.933

 APOE ε4-positive, n (%)

161 (35.7)

13 (9.9)

12 (30.8)

48 (42.5)

30 (44.8)

36 (57.1)

22 (57.9)

<0.001

Neuropsychological tests

 MMSE score, mean (SD)

23.3 (6.7)

29.0 (1.3)

27.7 (1.7)

25.8 (1.9)

21.9 (1.4)

15.7 (2.3)

7.4 (2.6)

<0.001

 Memorya, median [Q1, Q3]

−0.07 [−1.18, 0.72]

0.87 [0.56, 1.50]

0.16 [−0.23, 0.72]

−0.23 [−0.71, 0.72]

−0.71 [−1.18, −0.23]

−1.18 [−1.18, −0.82]

−1.18 [−1.18, −1.18]

<0.001

 Execution functiona, median [Q1, Q3]

0.43 [−1.25, 0.43]

0.43 [0.43, 0.43]

0.43 [0.43, 1.49]

−0.41 [−1.25, 1.28]

0.43 [−1.25, 0.43]

−1.25 [−1.25, −0.41]

−1.25 [−1.25, −1.25]

<0.001

 Attentiona, median [Q1, Q3]

0.43 [−0.39, 0.83]

0.83 [0.67, 0.83]

0.69 [0.40, 0.83]

0.43 [−0.21, 0.83]

−0.36 [−0.78, 0.43]

−1.46 [−1.99, −0.39]

−2.01 [−2.42, −2.01]

<0.001

 Languagea, median [Q1, Q3]

0.58 [−0.27, 0.72]

0.72 [0.58, 0.72]

0.58 [0.16, 0.72]

−0.27 [−0.66, 0.72]

−0.27 [−1.16, 0.72]

−0.27 [−1.26, 0.72]

−1.26 [−2.25, −0.27]

<0.001

 Visuospatial functiona, median [Q1, Q3]

0.31 [−0.63, 0.93]

0.93 [0.62, 0.93]

0.76 [0.31, 0.93]

0.15 [−0.32, 0.62]

−0.63 [−1.25, −0.005]

−1.25 [−1.87, −0.32]

−1.87 [−2.18, −1.02]

<0.001

  1. Note: aZ score transformed. NC, normal cognition; aMCI-s, amnestic mild cognitive impairment-single domain; aMCI-m, amnestic mild cognitive impairment-multiple domains; AD, Alzheimer’s disease clinical syndrome; CDR, Clinical Dementia Rating Scale; SD, standard deviation; Q1, quartile 1; Q3, quartile 3; APOE, apolipoprotein E; MMSE, mini-mental state examination